Robert Wood Johnson Medical School. April 28, 2014

Size: px
Start display at page:

Download "Robert Wood Johnson Medical School. April 28, 2014"

Transcription

1 Robert Wood Johnson Medical School April 28, 2014

2 Joanne Corbo, MBA HIV Program Manager

3 Website for NJ HIV Rapid Testing Support: njhiv.org

4 One Time Events Requests should be sent 10 business days in advance (No exceptions) Must use current form (electronic version on NJ HIV.org) Send to Sonya Thompson/copy to Joanne Corbo Approvals done by Sonya/PMO based on strict criteria for target population/prevalence (Criteria: zip code etc.) Results for One Day Events must be sent to Sonya Thompson/copy to Joanne Corbo within three business days of the event (electronic version on NJ HIV.org)

5

6

7

8 One-Day Event Results Report Submit one form per event within three business days of event Date of Event: Sponsoring Agency: Testing Agency (if different than sponsoring agency): Zipcode of Testing location: Target # # Population Positive Negative TOTAL 0 0 * General Population is any non targeted group Please complete the entire form. Totals will automatically add for you. "SAVE AS" naming the file with your agency name and date of event. to Joanne Corbo at corbojo@rwjmc.rutgers.edu and Sonya Thompson at sonya.thompson@doh.state.nj.us within three business days.

9 Test logs: RWJ test logs due the 10 th of the month May also be sent as they are completed Please make sure logs are complete Site Number, Contact Information, shipment number Test information complete: Pos, Neg, Temperature, Start Time End Time, Operator Initials If doing second test for another site indicate second test and site number of first site Fax to or

10 NJHIV Positive Tracking Form Use new form included in packet (available on NJ HIV.org) Must be sent in as completed to RWJ Fax to or

11

12 Discordant work up/ procedure: If second rapid or confirmatory does not match first rapid the result is discordant Draw blood for work up: Two white top tubes (must be spun down and frozen upside down) One serum separator (must be spun down and refrigerated) You must report all discordant results to RWJ Call Leave a message with contact information so RWJ pick up samples and process.

13 RWJ License renewals: License renewals sent with a checklist Coordinator must sign checklist to indicate all items necessary for regulatory compliance are in place at the site Send copy of standing order indicating it has reviewed and is current must be included Copy of standing order template included in packet (available on NJ HIV.org)

14 Checklist for License Renewal: Site Name We have the current signed RWJ NJ Rapid HIV Testing Support Program Policy Manual available at our testing location. We are using the current signed Exposure Control Plan provided in the RWJ NJ Rapid HIV Testing Support Program Policy Manual. We have a current signed Exposure Control Plan available at our testing location if we are not using the plan provided in the RWJ NJ Rapid HIV Testing Support Program Policy Manual. We have a copy of the standing order for performing Rapid HIV Testing signed by our current Medical Director or Authorized Physician at our testing location. The standing order has to be reviewed this year; We have documented that it is current and that the medical director (who signed it) has not changed. We have attached a copy of the standing order with our license application for RWJMS records. Signed by: Site Testing Coordinator

15 Standing Order Template To Whom It May Concern: This standing order shall constitute a request for rapid HIV testing for screenings performed at: Name of Testing Site: Address of Testing Site: In cases where a client receives a preliminary positive result using a rapid HIV test, this authorizes: HIV Western Blot and/or a second Rapid HIV test (for all preliminary positives); and follow-up testing as appropriate to the clinical setting which may include: Additional HIV serology HIV nucleic acid testing Signature Print Name Medical Director

16 Revised Frequently called Number List

17

18 Updated RWJ Rapid HIV Support Contact List

19 NJ HV > Grant from Division of HIV STD & TB Services Linda Berezny, RN PMO Dept. of Pathology & Lab Medicine Robert Wood Johnson Medical School Evan Cadoff, MD Professor & Chairman Eugene Martin, Ph.D. Professor Gratian Salaru, MD Asst. Professor Joanne Corbo, MBA, MT Program Manager TECHNICAL Latasha Adams, MT Moeen Ahmed, MT Claudia Carron, RN Aida Gilanchi, MT Franchesca Jackson, BS Jaclyn Kollinger, MT Nisha Patel, MT ADMINISTRATIVE Lisa May Karen Williams

20 RWJ Sites: African American Office of Gay Concerns Atlantic City Health Department AtlantiCare Mission Health (Atlantic City Corrections) Bergen County Health Department Buddies of NJ Burlington County Health Department Camden AHEC Camden County Health Departments Catholic Charities (Union County Jail and Hudson County Jail) Checkmate, Inc City of Trenton City of Vineland Complete Health Care, Inc. Cumberland County Health Department Dooley House East Orange Health Department Eric B. Chandler Health Center FamCare Hamilton Township STD Clinic Henry J. Austin Health Center Hispanic Family Center HiTops Inc Horizon Health Hunterdon Health Department Hyacinth Foundation Iris House John Brooks Recovery JSAS Kean University Kennedy Health La Casa Don Pedro Liberation in Truth Newark STD Clinic New Horizon Health Center NJCRI NJ React North Hudson Community Action Corporation(9 sites) Oasis Drop In Center Ocean County Health Department Ocean Health Initiatives Paterson Department of Health Proceed Robert Wood Johnson Medical School Saint James Social Services Salem County Health Middlesex County Public Health Department NAP Newark NAP Trenton Neighborhood Health Newark Community Health Center Department South Jersey AIDS Alliance (OASIS) Visiting Nurse Association of Asbury Park Well of Hope William Paterson University Woodbridge Department of Health

21 Non-RWJ Sites: Asbury Park Community Health Center/Visiting Nurse Association Atlantic County Health Department Atlanti-Care Regional Medical Center Cape May County Health Department Cooper Medical Center-ER Cooper Medical Center-EIP/Camden County Jail Gloucester County Health department Greater Northern Jersey Planned Parenthood (10 Sites) Hoboken Family Planning- 3 sites Hurtado Health Center (Rutgers) Jersey City Medical Center JFK Medical Center Monmouth Regional Medical Center Morristown Memorial Hospital Newark Beth Israel Ocean County Family Planning Our Lady of Lourdes Planned Parenthood Metro Planned Parenthood of Central NJ Planned parenthood of Hamilton Planned Parenthood of East Orange Planned Parenthood of Mercer County Planned Parenthood of Southern NJ Raritan Bay Medical Center Saint John s Clinic Saint Joseph s Medical Center Saint Michaels Medical Center South Jersey Family Medicine ( 7 sites) Trinitas Hospital UMDNJ University Hospital ER & STOP University of Princeton Health Center (McCosh Infirmary) Women s Health & Counseling Center - Somerville Zufall Health

22 LEGEND Symbol Rapid Testing PROGRAM COMMUNITY BASED ORG. (CBO) MEDICAL CTR. ER MOBILE VAN JAILS NJ HIV May, 2009

23 Evan Cadoff, MD...Gene Martin, PhD Gratian Salaru, MD

24 Background Failure to return (2005) Missed Opportunities AHI in NJ NAAT data (2012) Category C Outcomes Expansion of RTA sites in NJ Training in RTA 4 th Generation Lab-based Testing Transition to 4 th Generation POC Testing Current limitations on 4 th Gen POC Testing Master plan ( ) Build out of 4 th Gen. POC Collaboration to facilitate linkage (Orthogonal confirmation of 4 th Gen. Lab-based Positives) Validation of istoc is there a way to objectively read rapid tests

25 Traditional: EIA or IF confirmed by traditional methods: HIV Western blot, IFA or Aptima Rapid Testing Options: 1. Rapid HIV Screen confirmed by traditional methods (Western blot, IFA) 2. Rapid HIV Screen confirmed by an orthogonal rapid tests Rapid-Rapid Model Clearview StatPak confirmed by Trinity Unigold Rapid-2-Rapid Model 1. Clearview StatPak is performed at Site #1 2. Transportation of Client to Site #2 (Typically a medical care entity) 3. Patient Navigator at Site #2 performs second orthogonal rapid 4. If HIV POS Laboratory Intake 3. Rapid Screen Alone Rare in NJ

26 IDSA SAN FRANCISCO

27 RWJ Sites: 97 Non RWJ Sites: 64 RWJ sites: Non RWJ site: Rapid HIV Testing NJ 60 Primary 24 satellites 13 mobile 64 sites including 12 ERS Testing volume Rapid-Rapid format: 2013 Tested 48,708 PRELIM POS 450 UG PERFORMED 439 UG CONFIRMED 426 From Inception 175,630 PRELIMINARY POS 1,503 PRESUMPTIVE POSITIVES 1,407

28 When compared against current rapid HIV tests, NAAT tells us we re missing between 6-8% of those infected when we screen for antibodies using one of the traditional rapid HIV tests Those with the highest risk of infecting others are the ones that are being missed!! The same issues with patient return and process completion occur with NAAT that occur with traditional testing!!! Solution: A test that picks up p24 Ag COULD identify a substantial proportion of the same population. A POCT device could increase the pickup without losing the ability to link patients to care. E.G. Martin et al. / Journal of Clinical Virology 58S (2013) e24 e28 28

29 Program Dates Description Maryland 6/06-3/08 North Carolina Los Angeles NEWARK, NJ Seattle King County Atlanta 11/02-10/03 2/04-4/04 2/10 to 1/12 9/03-1/05 10/02-1/04 HIV Ab neg adults seen at two STD clinics (6/06-- 3/08); multiple venues 7/07-3/08) HIV Ab neg persons in North Carolina seeking HIV testing at 110 publicly funded sites (n = 109,250) HIV Ab neg men seeking HIV testing at three STD clinics (n = 1712) HIV Ab neg adults receiving testing and counseling at two high risk urban hospitals in Newark, NJ HIV Ab neg MSM seeking HIV testing through Seattle-King County (n = 3525) 2202 adults receiving HIV testing and counseling at three high risk urban sites in Atlanta, Georgia Rapid Tested NAAT Tested AHI HIV Ab+ % HIV Ab + % Inc in Yield % Yield AHI 58, , % 0.41% 0.01% 108, % 3.95% 0.02% 1, % 7.14% 0.06% 12,390 6, % 6.90% 0.12% 3, % 6.17% 0.15% 2, % 6.06% 0.19% San Francisco 10/03-7/04 HIV Ab neg persons seeking HIV testing at San Francisco Municipal STD clinic (n = 3075) 2, % 10.48% 0.40% 29

30 Receipt of Pooled RNA Results Never Receive Results AHI Received Results Too Late for Optimal 42% Intervention Patel et al, CDC, Archives Int Med

31 Acute HIV Infection 31

32 Because individuals with AHI are highly infectious, have engaged in high risk behaviors, and are often unaware of their status they contribute substantially to the spread of HIV. Although the duration of AHI is short (typically 3-4 weeks), studies have consistently shown that ~ 50% of new HIV transmissions are caused by onward transmission within the first six months from an individual with AHI % develop symptoms of Acute HIV 50%-90% who have symptoms seek medical care Of those diagnosed with Acute HIV, 50% of patients seen at least 3 times before they are diagnosed SYMPTOMS - ACUTE HIV INFECTION Rash &/or fever(s), possibly in combination with: Malaise Loss of Appetite Weight loss Sore Throat Mouth Sores Joint Pain Muscle Pain Swollen lymph nodes Diarrhea Fatigue Night sweats Nausea/vomiting Headache Genital Sores LINKAGE AND TREATMENT OPPORTUNITY!

33 HIV RNA in Semen (Log 10 copies/ml) (1/30-1/200) Risk of Transmission Male to Female - Blue Reflects Genital Viral Burden Yellow Effect of ART Theoretical - Red (1/1000 1/10,000) (1/500-1/2000) (1/100-1/1000) Acute Infection Asymptomatic Infection HIV Progression AIDS Cohen and Pilcher, JID 191:1391, 2005

34 Point of Care - Based Laboratory - Based 34

35 35

36 Substantially more sensitive than 3 rd Gen. HIV assays, earlier generation rapid HIV tests, and confirmatory assays Somewhat more sensitive than POC-based 4 th Gen. rapid HIV assay (Alere Determine Combo assay) They identify a significant proportion of acutely infected individuals (~90%) May be used in the diagnosis of HIV-1/HIV-2 infection in pediatric subjects (i.e., children as young as 2) and in pregnant woman Permit the identification of established HIV infections without the need to send-out for additional testing 36

37 Less sensitive than NAAT tests (individual or pooled); therefore MISSING some cases of AHI. Although the manufacturer claims it is ~ 35 minutes to an initial result, the reality is that in many laboratories the average time to an initial single result is much longer. Unfortunately, both FDA-approved lab-based assays report a single combined specimen result, so neither can differentiate initially between recent and established HIV infections. When used in conjunction with the new confirmatory algorithm they provide identification of individuals who have HIV antibodies, but require an additional NAAT test to rule in AHI. As of today, the only available 4 th gen. test that can on a preliminary basis identify recent infection is the standalone rapid test: The Determine Combo. 37

38 Architect package Insert: Fully-automated, random-access (no Control brackets) Stat capability HIV Combo assay: 29 minute time to first result >150 tests per hour on i2000sr >50 tests per hour on i1000sr Manutac et al. JCV. 58S (2013) e

39 Avg.: 57.7 min

40 4 th Generation HIV1/2 EIA Is it reproducible? If repeatedly reactive HIV-1/2 Differentiation Assay BIORAD MULTI-SPOT HIV + HIV-1 -/ HIV-2 - ANTIBODIES NEGATIVE or IND HIV-1 +/ HIV-2 HIV-1 antibodies detected Logistic delays? HIV-1 -/ HIV-2 + HIV-2 antibodies detected RNA Testing HIV-1 +/ HIV-2 + HIV antibodies detected Additonal Testing Required to rule out a dual infecton RNA + Acute HIV Infection RNA - NEGATIVE 40

41 Tests for the simultaneous and separate qualitative detection of free HIV-1 p24 antigen and antibodies to HIV-1 and HIV-2. Lot number Name of Test Patient Identification It is intended for use as a pointof-care test to aid in the diagnosis of infection with HIV-1 and HIV-2, including an acute HIV-1 infection, and may distinguish acute HIV-1 infection from established HIV-1 infection when the specimen is positive for HIV-1 p24 antigen and negative for anti-hiv-1 and anti- HIV-2 antibodies. Control Line Sample Pad p24 Antigen Result HIV Antibodies Result Highlights Alere Determine Ag/Ab Combo Alere Determine HIV-1/2 Ag/Ab Combo Package Insert Rev: /09 41

42 Seroconversion panels Determine HIV-1/2 (3 rd gen) Ab Day: Determine Combo (4 th gen) Ag Ab Day: Earlier detection Panel AS PRB943 (BBI, Seracare)

43 Seroconversion panels Determine HIV-1/2 Ab Nonreactive. Dismissed. Ab Determine Combo Ag Reactive. Presumably Recent infection. Ag Ab Day: 12 Panel AS PRB943 (BBI, Seracare)

44 Seroconversion panels: FDA approved assays 4 th Generation Lab Assays Days Before Western Blot positive * Modified from Silvina M, et al. Performance of the Alere DetermineTM HIV ½ Ag/Ab Combo Rapid Test with specimens from HIV-1 serocoverters from the US and HIV-2 Infected individuals from Ivory Coast. J Clin Virol 2013: Published Online 05 August DOI: /j.jcv

45 Order of sensitivity to acute HIV infection: Individual NAAT Aptima > Pooled NAAT >4 th Gen. Tests Lab-based 4 th Gen: Architect/Biorad >POCT based 4 th Gen: Determine Combo More than half of HIV transmission is thought to occur during the earliest phase of infection Weighing the potential benefit of slightly improved sensitivity versus the immediacy of the result is a decision that needs to be driven by a careful assessment of the circumstances involved in particular screening programs! 45

46

47 Rapid-Rapid Monthly Test Volume TotalTest 48, Rapid-Rapid Test Volume 2.2% Percent Refuse Unigold Verification Percent of Prelim Positive Results not Verified by 5.3% Unigold Percent UG Verified Connected to Care on Same 62.9% Day 2.3% Percent UG Failed to Verify of UG Performed

48 GOAL: Simplify the process. Maximize linkage and re-engagement. More clients complete testing and are linked to care on the same day using an RTA. Average time to lab intake for HIV+ positives is < 2 business days 175,630 RTA Testing Volume SINCE INCEPTION 5.7% Percent Refuse Western blot 2.5% Percent Refuse Unigold Verification Percent of Prelim Positive Results not Verified 3.9% by Unigold 2013 New Pos Re-Engaged Already in Care Client Refused Denied Charity Care No Show Bus Days to Lab Intake 344 POS from Apr - Dec SUBTOTAL RTA POS Distribution 1% 9% 3% 6% New Pos 26% 55% Re-Engaged Already in Care Client Refused Denied Charity Care No Show

49 NJ Hospitals have been slow to adopt 4 th Gen. HIV Category C project encouraged the transition by supporting ED testing in 2013: St. Joseph s Medical Center (89% complete) Contract: 2000 tests To Date: 1782 tests, 7 Positives 0 AHI, 7 Established Infections, Several FP Architects Our Lady of Lourdes (80% complete) Renewed Contract: 3600 tests To Date: 2881 tests, 18 Positives 3 AHI, 9 Established Infections, 3 FP Architect, 3 FP StatPak Jersey Shore Univ. Medical Center (30%) Contract: 2400 To Date: 70 tests, 2 Positive 0 AHI

50 Increase RTA availability in NJ: - Added 11 facilities including 8 hospitals and 1 multi-facility FQHC - Currently RTA testing exceeds 48,000 tests per year at rapidrapid facilities - Expand the program to include additional Rapid-2-Rapid screening ONLY sites - Reduces QC costs at sites with relatively few positives Recruit Mod. Complex. Facilities to implement 4 th gen. POC testing 3 hospitals have agreed 2 additional facilities have agreed 1 site begun RWJMS Question: How to integrate 4 th gen. POC and lab-based? Consider using Determine Combo as an orthogonal confirmation expediting identification of AHI at hospitals

51 OVERALL GOAL APPROACH OUTCOMES Expand RTA by an additional 9 sites, currently performing Traditional HIV testing estimated to test 29,000/year 1. Approach Non-RWJ laboratory directors utilizing existing HIV site coordinators to gain entry and begin educational process with Bioanalytical Lab Directors 2. Encourage laboratory representation at various state planning meetings related to Linkage to Care and RTA testing. 3. Publish and Present information about RTA guidelines and Presumptive Positives 1. Eleven sites added: Monmouth Regional Med Ctr./Jersey Shore Medical Center Trinitas Hospital Camden County Jail Raritan Bay Medical Center Jersey City Medical Center St. Joseph's Our Lady of Lourdes City of Trenton UMDNJ/UH ER Newark Beth Israel North Hudson Community Action (Multi-site FQHC) Rapid-Rapid Testing 48,000 Navigator - 67 (R2R) conducted; 96% positive (4% discordant) and all +s (100%) enrolled in care 3. Ms. Corbo has joined the NJ HIV Planning Group, joined numerous collaborative meetings 4, Since 2005: Abstracts: posters 15 platform presentations papers 3 platform presentations

52 OVERALL GOAL APPROACH OUTCOMES Prepare to Implement Point-of- Care 4 th Generation Testing in the absence of CLIA WAIVER Prepare to transition existing Lab-based 4 th generation testing to POC-based 4 th generation tests Transition selected POC 2nd generation testing (StatPak) to POC-based 4 th gen. tests (Determine Combo) 1. Validate assay using available Performance Panels 2. Develop procedures, forms, training program 3. Identify method for Proficiency Testing 4. Set-up Pilot Site 1. Approach existing Lab-based 4 th gen. sites and their non- RWJ Bioanalytical Lab Directors regarding interest in licensing Determine prior to CLIA-Waiver 2. Consider using Determine Combo as an orthogonal confirmation expediting identification of AHI 1. Approach higher prevalence locations to transition initial HIV screen to Determine Combo 1. Assay performance validated 2. Procedures, forms and training program completed 3. Pilot site: RWJ 003 Site (Mod. Complexity) trained. Testing has begun. 1. Requests initiated to: Jersey Shore Medical Ctr. - Neptune Our Lady of Lourdes Camden St. Joseph s Med. Ctr. - Paterson 1. Requests accepted by: NJCRI Newark Complete Healthcare Neighborhood Health

53 Thanks! 53

54 Site Number Site Description MONTH Clients Tested by StatPak Prelim Positive UniGold Performed UniGold Confirmed UniGold Refusal Number of Discordant NOTES 6364 CTR Walk -IN Jan Emergency Room Jan Community 6587 Outreach Jan Lennard Clinic Jan

55 SITE Number IF R-2- R please indicate screeni ng SITE Number Date /9/ /15/ /27/ /27/ /29/ /30/ /8/ /16/ /22/ /29/ /15/14 Positive Client CTS Number NEW POS x X RE- ENGAGED x X X X ALREADY IN-Care Appt. Date 1/17/1 4 1/15/1 4 1/27/1 4 1/30/1 4 1/29/1 4 1/30/1 4 Appt. KEPT Bus Days to Lab Intake No Show Narrative Client couldn t link the same day because client didn t have any identification. Client stated it was lost; he had no insurance which meant he had to apply for charity care which requires I.D. Client returned on January 17 th with I.D. and was linked to care the same day. yes 5 yes 0 Yes 0 yes 3 Yes 0 Yes 0 Client was linked to care the same day. Client currently in care. Client was linked to care the same day. Client currently in care. Client stated he had to go out of town for a few days and when he returned on the 30 th he would commit to care. Client came in on the 30 th and was linked to care. Client was linked to care the same day. Client currently in care. Client was linked to care the same day. Client is currently in care. X 1/8/14 Yes 1 Client was linked to care the same day. Client is currently in care. X X 1/17/1 4 1/22/1 4 Yes 1 Client was linked to care on the 17 th the next business day and is currently in care. Yes 5 x No No - x 1/24/1 4 Yes 7 Client was linked to care the same day. Client is currently in care. Client refused linkage to care stated he wasn t interested. Patient Navigator will follow up with client. Client was a Rapid to Rapid referral from the Lennard Clinic. Although client was tested and referred from the Lennard Clinic on 1/15/14 he didn t come in for confirmatory testing until the 24 th. Client stated he couldn t stay to be linked to care on the 24 th and

56 GOAL: Simplify the process. Maximize linkage and re-engagement. More clients complete testing and are linked to care on the same day using an RTA. Average time to lab intake for HIV+ positives is < 2 business days 175,630 RTA Testing Volume SINCE INCEPTION 5.7% Percent Refuse Western blot 2.5% Percent Refuse Unigold Verification Percent of Prelim Positive Results not Verified by 3.9% Unigold 2013 (344 POS from Apr - Dec) New Pos Re- Engaged Already in Care Client Refused Denied Charity Care No Show Bus Days to Lab Intake SUBTOTAL % 2013 RTA POSITIVE Distribution 6% 9% 3% New Pos 26% 55% Re- Engaged

57 RWJ Sites: Non-RWJ Sites: African American Office of Gay Concerns Burlington County Health Department Atlantic City Health Department Camden AHEC AtlantiCare Mission Health (Atlantic City Corrections) Camden County Health Departments City of Trenton City of Vineland Complete Health Care, Inc. East Orange Health Department Hispanic Family Center Iris House Liberation in Truth Newark Community Health Center North Hudson Community Action Corporation(9 sites) Proceed Visiting Nurse Association of Asbury Park Eric B. Chandler Health Center FamCare Bergen County Health Department Catholic Charities (Union County Jail and Hudson County Jail) Cumberland County Health Department Hamilton Township STD Clinic HiTops Inc Horizon Health Hunterdon Health Department John Brooks Recovery Middlesex County Public Health Department Newark STD Clinic Oasis Drop In Center Robert Wood Johnson Medical School Well of Hope Buddies of NJ Checkmate, Inc Dooley House Henry J. Austin Health Center Hyacinth Foundation JSAS Kean University La Casa Don Pedro NAP Newark NAP Trenton Neighborhood Health New Horizon Health Center Ocean County Health Department Saint James Social Services William Paterson University NJCRI Ocean Health Initiatives Salem County Health Department NJ React Paterson Department of Health South Jersey AIDS Alliance (OASIS) in licensing process Asbury Park Community Health Center/Visiting Nurse Association Cooper Medical Center- EIP/Camden County Jail Jersey City Medical Center Ocean County Family Planning Planned Parenthood of East Orange Saint Joseph s Medical Center University of Princeton Health Center (McCosh Infirmary) Atlantic County Health Department Gloucester County Health department JFK Medical Center Our Lady of Lourdes Planned Parenthood of Mercer County Saint Michaels Medical Center Women s Health & Counseling Center - Somerville Atlanti-Care Regional Medical Center Greater Northern Jersey Planned Parenthood (10 Sites) Monmouth Regional Medical Center Planned Parenthood Metro Planned Parenthood of Southern NJ South Jersey Family Medicine ( 7 sites) Zufall Health Cape May County Health Department Hoboken Family Planning- 3 sites Morristown Memorial Hospital Planned Parenthood of Central NJ Raritan Bay Medical Center Trinitas Hospital Cooper Medical Center-ER Hurtado Health Center (Rutgers) Newark Beth Israel Planned parenthood of Hamilton Saint John s Clinic University Hospital - Newark ER & STOP

58 ARTICLES: Since Paul SM, Cadoff EM, and Martin E. Rapid Diagnostic Testing for HIV Clinical Implications. Clinical Virology and Infectious Disease Paul S, Cadoff E, and Martin E. Rapid Diagnostic Testing for HIV: Clinical Implications of a New Diagnostic Tool. New Jersey AIDSLine. 2005; 1: Paul S, Cadoff E, Martin E, Wolski M, Nichol L, Williams R, Harvey-Talbot M, Bruccoleri P, Maung A, Martin R, and Berezny L. Rapid HIV Testing in New Jersey Hospital Emergency Departments. New Jersey AIDSLine, 2005:2(1): Shah MB, Paul SM, Bishburg, E, and Martin EG. Update on HIV and Hepatitis C Virus Co-Infection. New Jersey AIDSLine. 2(2): 3-10, Gentz M, Paul SM and Martin EG. 2(4): 4-11, Hepatitis B and HIV Co-infection. New Jersey AIDSLine, 6. Jafa K, Patel P, MacKellar DA, Sullivan PS, Delaney KP, Sides TL, Newman AP, Paul SM, Cadoff EM, Martin EG, Keenan PA and Branson BM for the OraQuick Study Group. (2007) Investigation of False Positive Results with an Oral Fluid Rapid HIV-1/2 Antibody Test. PLoS ONE 2(1): e185. doi: /journal.pone Paul SM, Martin RM, Lin Y, Lu SE, Cadoff EM and Martin EG. Voluntary Rapid HIV Testing in Emergency Departments in New Jersey. Garden State Focus. 53(3): 23-25, November/December Cadoff EM, Salaru G, Marone R, Gaur S, Paul SM and Martin EG. Integrating Rapid HIV Testing in Emergency Care Improves HIV Detection. Point of Care. 6(3): 1-7, Martin, EG and MA Newton. Rapid HIV Testing. In Czech and Slovaks in an International and Global context: Proceedings of the 23 th SVU World Congress. Editors: M. Rechcigl, V. Papusck and M. Bauer. Univ. of S. Bohemia, 2008, Paul SM and Martin EG. HIV Test Recommendations, Assay Selection. ADVANCE for Administrators of the Laboratory, 17(7): 86-92, Paul, SM and Martin, EG. HIV Testing Update. New Jersey AIDSLine, 9(1):14-28, Wesolowski1 LG, Ethridge SF, Martin EG, Cadoff EM and MacKellar DA. Rapid Human Immunodeficiency Virus (HIV) Test Quality Assurance Practices and Outcomes among Testing Sites Affiliated with 17 Public Health Departments. Journal of Clinical Micro. October : ; doi: /jcm Epub 2009 Aug Martin EG, Salaru G, Paul, SM and Cadoff EM. Use of a Rapid HIV Testing Algorithm to Improve Linkage to Care. Journal of Clinical Virology Dec; 52 Suppl 1:S11-5. Epub 2011 Oct 7. PMID: Stevinson K., Martin EG, Marcella S, Paul SM. Cost Effectiveness Analysis of the New Jersey Rapid Test Algorithm for HIV Testing In NJDHSS Funded Testing Sites. Journal of Clinical Virology S: S Epub 2011 Nov 9. PMID: Martin EG. Current US HIV Public Health Strategies: Reflections on an Era of Globalization and Transatlantic Collaboration. Proceedings of the 26 th SVU World Congress. Volume 1. Editors: Z. David, K. Raska and E.G. Martin. Czechoslovak Society of Arts and Sciences (SVU) ISBN Martin, EG, Salaru G, Mohammed D, Coombs R, Paul S and Cadoff E. Finding those at risk: AHI in Newark, NJ. Journal of Clinical Virology. 58S (2013) e24 e Mohammed DY, Martin EG, Sadashigie C, Jaker M, and Paul SM An Anonymous Unlinked Survey of the Sero-Prevalence of HIV/HCV antibody in an Urban Emergency Department Journal of Clinical Virology. 58S (2013) e19 e23. Since 2005 ABSTRACTS: 44 absracts 29 posters - 15 PLATFORM PRESENTATIONS:

Rapid testing algorithm performance in a low prevalence environment: NJ

Rapid testing algorithm performance in a low prevalence environment: NJ Rapid testing algorithm performance in a low prevalence environment: NJ 2015-8 Alere Determine HIV-1/2 Ag/Ab Combo Trinity Biotech Uni-Gold HIV1/2 Recombigen Eugene G. Martin, PhD HIV Diagnostics Conference

More information

NJHIV DMHAS Rapid HIV Testing Program Overview

NJHIV DMHAS Rapid HIV Testing Program Overview NJHIV DMHAS Rapid HIV Testing Program Overview Division of Mental Health and Addiction Services (DMHAS) NJHIV WHO WE ARE Rapid HIV testing support group Composed of laboratorians MD, PhD, MT, RN Department

More information

NJ PrEP Initiative Update

NJ PrEP Initiative Update NJ PrEP Initiative Update New Jersey Department of Health Division of HIV, STD and TB Services (DHSTS) ANNUAL HIV TESTING SITE COORDINATORS MEETING PRINCETON, NJ May 10, 2018 Steven Saunders, MS Director,

More information

Robert Wood Johnson Medical School NJ HIV: Status Update

Robert Wood Johnson Medical School NJ HIV: Status Update Robert Wood Johnson Medical School NJ HIV: Status Update Eugene G. Martin, Ph.D Professor of Pathology and Laboratory Medicine Co-Director, NJ HIV Rutgers, The State University of New Jersey 1. NJ HIV

More information

NJ RAPID HIV TESTING SUPPORT PROGRAM

NJ RAPID HIV TESTING SUPPORT PROGRAM PROGRAM OVERVIEW Program Description: Point of Care testing may seem, on its face, simple and 'fool proof', but in a study conducted by HCFA in Colorado and Ohio, quality problems were identified in more

More information

Syphilis Screening in the Community

Syphilis Screening in the Community Syphilis Screening in the Community A NJ DOH DHSTS Pilot Project Eugene G. Martin, Ph.D Co-Director, NJ HIV Professor of Pathology and Laboratory Medicine Rutgers University Robert Wood Johnson Medical

More information

ARCHITECT HIV Ag/Ab Combo: Moving HIV Diagnostics Forward in the U.S.

ARCHITECT HIV Ag/Ab Combo: Moving HIV Diagnostics Forward in the U.S. ARCHITECT HIV Ag/Ab Combo: Moving HIV Diagnostics Forward in the U.S. Catherine Brennan, Ph.D. Research Fellow Infectious Diseases Research Abbott Diagnostics 1 Agenda ARCHITECT HIV Ag/Ab Combo Assay What

More information

NJHIV DMHAS Mobile Counselor Pilot Program. Division of Mental Health and Addiction Services (DMHAS)

NJHIV DMHAS Mobile Counselor Pilot Program. Division of Mental Health and Addiction Services (DMHAS) NJHIV DMHAS Mobile Counselor Pilot Program Division of Mental Health and Addiction Services (DMHAS) HIV RAPID TEST SUPPORT in NEW JERSEY DIVISION OF MENTAL HEALTH AND ADDICTION SERVICES Division of Mental

More information

NJ PrEP Initiative Update

NJ PrEP Initiative Update NJ PrEP Initiative Update New Jersey Department of Health Division of HIV, STD and TB Services (DHSTS) ANNUAL HIV TESTING SITE COORDINATORS MEETING May 16, 2017 Steven Saunders, MS Director, HIV Prevention,

More information

HIV Test Technologies, Best Practices, and New Algorithm. Jenny R. McFarlane DSHS HIV Prevention and Care Branch

HIV Test Technologies, Best Practices, and New Algorithm. Jenny R. McFarlane DSHS HIV Prevention and Care Branch HIV Test Technologies, Best Practices, and New Algorithm Jenny R. McFarlane DSHS HIV Prevention and Care Branch Testing History 1985 1 st Gen HIV-1 IA 1987 HIV-1 WB 1990 HIV-2 IA HIV-1 IA DBS 1991 2 nd

More information

RAPID-2-RAPID SEPTEMBER 2012 WHERE WE CAME FROM WHERE WE ARE & WHERE WE RE GOING!

RAPID-2-RAPID SEPTEMBER 2012 WHERE WE CAME FROM WHERE WE ARE & WHERE WE RE GOING! RAPID-2-RAPID EUGENE MARTIN, PH.D. PROFESSOR OF PATHOLOGY & LABORATORY MEDICINE UMDNJ ROBERT WOOD JOHNSON MEDICAL SCHOOL JOANNE CORBO, MT (ASCP) MBA HIV PROGRAM MANAGER NJ HIV SEPTEMBER 2012 WHERE WE CAME

More information

UPDATE HIV Coordinators Meeting 2018 NEW JERSEY HOSPITAL ASSOCIATION MAY 10, 2018

UPDATE HIV Coordinators Meeting 2018 NEW JERSEY HOSPITAL ASSOCIATION MAY 10, 2018 HIV Coordinators Meeting 2018 UPDATE - 2018 NEW JERSEY HOSPITAL ASSOCIATION MAY 10, 2018 Rutgers, The State University of New Jersey Eugene G. Martin, Ph.D Professor of Pathology and Laboratory Medicine

More information

THANK YOU! AETC Education and Training Center for your support of the NJ HIV COORDINATOR S MEETING

THANK YOU! AETC Education and Training Center for your support of the NJ HIV COORDINATOR S MEETING THANK YOU! AETC Education and Training Center for your support of the NJ HIV COORDINATOR S MEETING PLEASE COMPLETE THE EVALUATION FORM!! IN YOUR FOLDER!! NJ HIV COORDINATORS MEETING May 16, 2017 New Jersey

More information

DETERMINE SPECIMEN REQUIREMENTS HIV-1/2 Ag/Ab Combo TESTING PROCEDURE

DETERMINE SPECIMEN REQUIREMENTS HIV-1/2 Ag/Ab Combo TESTING PROCEDURE DETERMINE SPECIMEN REQUIREMENTS HIV-1/2 Ag/Ab Combo TESTING PROCEDURE PRINCIPLE: The Determine HIV-1/2 Ag/Ag Combo assay is a qualitative immunoassay for the simultaneous detection of Human Immunodeficiency

More information

Membership List by Agency

Membership List by Agency Membership List by Agency Strategic Direction They Represent Agency or Organization # of Representatives County Tobacco Free Living Active Living and Health Eating Increased Use of High Impact Quality

More information

The Evolving Landscape of HIV Prevention and Diagnosis

The Evolving Landscape of HIV Prevention and Diagnosis The Evolving Landscape of HIV Prevention and Diagnosis Jenny R. McFarlane Texas Department of State Health Services HIV/STD/TB/Viral Hepatitis Unit Is it okay if we just talk? NHAS: A Call to ACT Reduce

More information

ANTIBODY SCREENING by Uni-Gold Recombigen HIV

ANTIBODY SCREENING by Uni-Gold Recombigen HIV ANTI-HIV SPECIMEN 1 REQUIREMENTS ANTIBODY SCREENING by Uni-Gold Recombigen HIV PRINCIPLE: The Uni-Gold Recombigen HIV was designed as a rapid immunoassay and is intended to detect antibodies to HIV- 1

More information

HIV Testing Technology and the Latest Algorithm

HIV Testing Technology and the Latest Algorithm HIV Testing Technology and the Latest Algorithm David Warshauer, PhD, D(ABMM) Deputy Director, Communicable Diseases Wisconsin State Laboratory of Hygiene HIV Testing has changed over time Patients with

More information

1 st and 2 nd Generation EIA

1 st and 2 nd Generation EIA HIV Diagnostic Tests Bernard M. Branson, M.D. Associate D irector for Laboratory D iagnostics Division of HIV/AIDS Prevention Centers for D isease Control & Prevention The views expressed in this presentation

More information

New Jersey Department of Health and Senior Services. Recommendations for Adult Closed Acute Care Inpatient Psychiatric Beds

New Jersey Department of Health and Senior Services. Recommendations for Adult Closed Acute Care Inpatient Psychiatric Beds JON S. CORZINE Governor DEPARTMENT OF HEALTH AND SENIOR SERVICES PO BOX 360 TRENTON, N.J. 08625-0360 www.nj.gov/health HEATHER HOWARD Commissioner TO: FROM: New Jersey State Health Planning Board New Jersey

More information

2018 HIV and HCV Diagnostic Testing Survey

2018 HIV and HCV Diagnostic Testing Survey 2018 HIV and HCV Diagnostic Testing Survey This survey is designed to capture the 2017 HIV and HCV testing practices in state and local public health laboratories (PHL). The results of the survey will

More information

NEW JERSEY HIV/AIDS REPORT

NEW JERSEY HIV/AIDS REPORT NEW JERSEY HIV/AIDS REPORT June 30, 2009 Jon S. Corzine Governor Public Health Services Branch Division of HIV/AIDS Services preventing disease with care Heather Howard Commissioner 2 Division of HIV/AIDS

More information

Routine HIV Testing Community of Practice Session #2

Routine HIV Testing Community of Practice Session #2 Routine HIV Testing Community of Practice Session #2 Presenters: Denver Prevention Training Center Broward Community & Family Health Centers, Inc. 20 March 2016 Communities of Practice Routine HIV Testing

More information

UnitedHealthcare Dual Complete ONE (HMO SNP) New Jersey

UnitedHealthcare Dual Complete ONE (HMO SNP) New Jersey UnitedHealthcare Dual Complete ONE (HMO SNP) New Jersey Agenda Overview Service Area Contracting Member ID Cards Sample Member ID Card Checking Member Enrollment Claim Submission Additional Benefits Additional

More information

Joanne Stekler, MD, MPH Assistant Professor of Medicine Deputy Director, Public Health Seattle & King County HIV/STD Program

Joanne Stekler, MD, MPH Assistant Professor of Medicine Deputy Director, Public Health Seattle & King County HIV/STD Program NORTHWEST AIDS EDUCATION AND TRAINING CENTER HIV Testing Joanne Stekler, MD, MPH Assistant Professor of Medicine Deputy Director, Public Health Seattle & King County HIV/STD Program Presentation prepared

More information

Statewide Influenza Activity Levels. 0=No report/activity 1=Sporadic 2=Local 3= Regional 4=Widespread

Statewide Influenza Activity Levels. 0=No report/activity 1=Sporadic 2=Local 3= Regional 4=Widespread Communicable Disease Service Influenza Activity Summary Week Ending October 3, 7 (MMWR Week 4) Influenza activity level: NO ACTIVITY No Activity- At least of 3 parameters at or below state baseline AND

More information

Opportunities Created by Diagnostic HCV and HIV Nucleic Acid Tests

Opportunities Created by Diagnostic HCV and HIV Nucleic Acid Tests Opportunities Created by Diagnostic HCV and HIV Nucleic Acid Tests Ann Winters, MD Medical Director, Viral Hepatitis Program, Bureau of Communicable Disease, New York City Department of Health and Mental

More information

Estimated HIV/AIDS Newly Diagnosed Cases In New Jersey

Estimated HIV/AIDS Newly Diagnosed Cases In New Jersey Introduction n As of 12/31/2009 there were more than 73,800 HIV/ AIDS cases in New Jersey including 1,353 pediatric HIV/AIDS cases. Over 4,000 children were also exposed to HIV. Over half of the cumulative

More information

Point-of-care HIV testing

Point-of-care HIV testing Point-of-care HIV testing Joanne Stekler, MD MPH Associate Professor University of Washington December 5, 2016 Disclaimer: The findings and conclusions in this presentation are those of the author(s) and

More information

Evolution of HIV Diagnostics. Goals for the 2010 Conference. Bernard M. Branson, M.D. CDC Division of HIV/AIDS Prevention

Evolution of HIV Diagnostics. Goals for the 2010 Conference. Bernard M. Branson, M.D. CDC Division of HIV/AIDS Prevention Evolution of HIV Diagnostics and Goals for the 2010 Conference Bernard M. Branson, M.D. Associate Director for Laboratory Diagnostics CDC Division of HIV/AIDS Prevention Evolution or other influences like

More information

HIV Update in Laboratory Testing. Patricia Slev, PhD, D(ABCC)

HIV Update in Laboratory Testing. Patricia Slev, PhD, D(ABCC) HIV Update in Laboratory Testing Patricia Slev, PhD, D(ABCC) Objectives Explain the advances in HIV diagnostics, including fourth generation Ag/Ab combination HIV screening assays Describe the new CDC

More information

A Summary of Clinical Evidence

A Summary of Clinical Evidence A Summary of Clinical Evidence Supporting the use of the Alere Determine HIV-1/2 Ag/Ab Combo Rapid Test to assist in the diagnosis of Human Immunodeficiency Virus (HIV) TAP HERE TO SEE THE PRODUCTS Table

More information

DMHAS FEE FOR SERVICE PRIOR AUTHORIZATION CONTACTS AGENCY NAME CONTACT PHONE

DMHAS FEE FOR SERVICE PRIOR AUTHORIZATION CONTACTS AGENCY NAME CONTACT  PHONE 5034 Atlantic Ave. OPCO LLC Advanced Behavioral Care Services AGAPE Counseling Services, Inc. Airmid Counseling Services ALFRE, Inc. ( Mrs. Wilsons Halfway House) American Habitare & Counseling, Inc. Angel

More information

APHL/CDC HIV Demonstration Project Demonstration Project for HIV Nucleic Acid Testing (NAT) Referral Updated: January 2018

APHL/CDC HIV Demonstration Project Demonstration Project for HIV Nucleic Acid Testing (NAT) Referral Updated: January 2018 APHL/CDC HIV Demonstration Project Demonstration Project for HIV Nucleic Acid Testing (NAT) Referral Updated: January 2018 Shipping and Submission Instructions Thank you for participating as a submitting

More information

NEW JERSEY HIV/AIDS REPORT

NEW JERSEY HIV/AIDS REPORT NEW JERSEY HIV/AIDS REPORT December 31, 2009 Chris Christie Governor Kim Guadagno Lt. Governor Public Health Services Branch Division of HIV/AIDS Services preventing disease with care Poonam Alaigh, MD,

More information

HIV: 2009 DIAGNOSTIC SURVEY FACING NEW CHALLENGES

HIV: 2009 DIAGNOSTIC SURVEY FACING NEW CHALLENGES ISSUES IN BRIEF: MEMBER SURVEY OF HIV ASSAY USE ASSOCIATION OF PUBLIC HEALTH LABORATORIES MARCH 2010 HIV: 2009 DIAGNOSTIC SURVEY FACING NEW CHALLENGES Twenty years ago, the Association of Public Health

More information

HIV Testing & Linkage to Care Services Provider Guidance Webinar

HIV Testing & Linkage to Care Services Provider Guidance Webinar HIV Testing & Linkage to Care Services Provider Guidance Webinar March 10, 2014 Division of HIV/STD/HCV Prevention Presenters: Mara San Antonio-Gaddy, AIDS Program Manager Ron Massaroni, Director Data

More information

Model Performance Evaluation Program (MPEP) HIV Rapid Testing Survey: Report of Sample Shipment Results, September 2009

Model Performance Evaluation Program (MPEP) HIV Rapid Testing Survey: Report of Sample Shipment Results, September 2009 Use of trade names and commercial sources is for identification only and does not constitute endorsement by the Public Health Service or the U.S. Department of Model Performance Evaluation Program (MPEP)

More information

Influenza Activity Level 3 ILI 5 Activity

Influenza Activity Level 3 ILI 5 Activity Respiratory Virus Surveillance Report 1 New Jersey Department of Health Communicable Disease Service Week ending December 3, 217 (MMWR week 52 2 ) Week 4 Week 45 Week 5 Week 3 Week 8 Week 13 Week 18 Week

More information

The Latest in HIV Tests: What Do the Results Mean?

The Latest in HIV Tests: What Do the Results Mean? The Latest in HIV Tests: What Do the Results Mean? Bernard M. Branson MD Principal Consultant, Scientific Affairs LLC Atlanta, Georgia Objectives At the end of this workshop, participants will be able

More information

HIV/AIDS Surveillance and Reporting Requirements

HIV/AIDS Surveillance and Reporting Requirements HIV/AIDS Surveillance and Reporting Requirements New Jersey Department of Health & Senior Services Division of HIV, STD, TB Services Princeton, NJ March 21, 2012 1 Introduction Review HIV Reporting Requirements

More information

New Generation of Nucleic Acid Testing. Michele Owen, Ph.D Division of HIV/AIDS Prevention Centers for Disease Control & Prevention

New Generation of Nucleic Acid Testing. Michele Owen, Ph.D Division of HIV/AIDS Prevention Centers for Disease Control & Prevention New Generation of Nucleic Acid Testing Michele Owen, Ph.D Division of HIV/AIDS Prevention Centers for Disease Control & Prevention Percentage (%) Persons Living with Diagnosed or Undiagnosed HIV Infection

More information

HIV Screening & Consent for Testing

HIV Screening & Consent for Testing 1. Algorithm for HIV Screening 2. Screening & Consent for HIV Testing a. Offering testing b. Counseling on HIV Risk Factors c. Pre-test Counseling d. Post-test Counseling 1. Positive Result 2. Preliminary

More information

Influenza Activity Level 3 ILI 5 Activity

Influenza Activity Level 3 ILI 5 Activity Respiratory Virus Surveillance Report 1 New Jersey Department of Health Communicable Disease Service Week ending February 1, 218 (MMWR week 6 2 ) Week 4 Week 45 Week 5 Week 3 Week 8 Week 13 Week 18 Week

More information

Overview of HIV Testing Practices and Technology

Overview of HIV Testing Practices and Technology Overview of HIV Testing Practices and Technology 2019 HIV Diagnostics Conference March 25 th, 2019 Michele Owen, Ph.D National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention Centers for Disease

More information

New Jersey HIV/AIDS Epidemiologic Profile 2011

New Jersey HIV/AIDS Epidemiologic Profile 2011 New Jersey HIV/AIDS Epidemiologic Profile 2011 HIV/AIDS in New Jersey New Jersey ranks 5th among 46 states with long-term namebased reporting in the rate of HIV (not AIDS) infection among adults and adolescents

More information

DMHAS FEE FOR SERVICE PRIOR AUTHORIZATION CONTACTS

DMHAS FEE FOR SERVICE PRIOR AUTHORIZATION CONTACTS AGAPE Counseling Services, Inc. ALFRE, Inc. ( Mrs. Wilsons Halfway House) American Habitare & Counseling, Inc. Anderson House Another Door Opens Recovery Center, LLC Atlantic Prevention Resources Atlanticare

More information

Learning Objectives. New HIV Testing Algorithm from CDC. Overview of HIV infection and disease 3/15/2016

Learning Objectives. New HIV Testing Algorithm from CDC. Overview of HIV infection and disease 3/15/2016 New HIV Testing Algorithm from CDC ASCLS-Michigan March 31, 2016 Dr. Kathleen Hoag Learning Objectives Following attendance and review of material provided, attendees will be able to: 1. Describe the new

More information

Advantages and disadvantages of different types of FDA-approved HIV immunoassays used for screening by generation and platform*

Advantages and disadvantages of different types of FDA-approved HIV immunoassays used for screening by generation and platform* Advantages and disadvantages of different types of FDA-approved HIV immunoassays used for screening by generation and platform* HIV immunoassays grouped by generation, platform, and CLIA complexity + Advantages

More information

2006 HIV Diagnostics Survey

2006 HIV Diagnostics Survey Public Health Laboratory Issues in Brief: 2006 HIV Diagnostics Survey Association of Public Health Laboratories November 2007 Background Nearly 20 years ago, the Association of Public Health Laboratories

More information

New Jersey HIV/AIDS Epidemiologic Profile 2010

New Jersey HIV/AIDS Epidemiologic Profile 2010 New Jersey HIV/AIDS Epidemiologic Profile 00 Estimated HIV/AIDS Cases, Deaths and Persons Living with HIV/AIDS -- New Jersey, 989-008 In 008, the latest complete year of diagnosis data, there were 350

More information

AccuSet Anti-HIV-1 Mixed Titer Performance Panel

AccuSet Anti-HIV-1 Mixed Titer Performance Panel PACKAGE INSERT PRB205(M3) / (0800-0379) INTENDED USE The Performance Panel PRB205(M3) / (0800-0379) is intended for use by diagnostics manufacturers and clinical laboratorians to evaluate their HIV-1 test

More information

AccuVert HIV-1 Seroconversion Panel PRB974 ( )

AccuVert HIV-1 Seroconversion Panel PRB974 ( ) PACKAGE INSERT PRB974 (0600-0258) INTENDED USE PRB974 (0600-0258) is a group of serial bleeds from an individual plasma donor during seroconversion. This panel is intended for use by diagnostics manufacturers

More information

HOPE Follow-Up Algorithm: Unusual Cases. Urvi Parikh, PhD MTN Virology Core Regional Meeting Lab Breakout Sept 27-28, 2016, Cape Town

HOPE Follow-Up Algorithm: Unusual Cases. Urvi Parikh, PhD MTN Virology Core Regional Meeting Lab Breakout Sept 27-28, 2016, Cape Town HOPE Follow-Up Algorithm: Unusual Cases Urvi Parikh, PhD MTN Virology Core Regional Meeting Lab Breakout Sept 27-28, 2016, Cape Town MTN-025 Testing Algorithm Screening/Enrollment MTN-025 Testing Algorithm

More information

NEW JERSEY HIV/AIDS REPORT

NEW JERSEY HIV/AIDS REPORT NEW JERSEY HIV/AIDS REPORT December 31, 2014 Chris Christie Governor Kim Guadagno Lt. Governor Public Health Services Branch Division of HIV, STD and TB Services preventing disease with care Mary E. O

More information

A Successful HIV Testing Quality Assurance Program: New York State Experience

A Successful HIV Testing Quality Assurance Program: New York State Experience A Successful HIV Testing Quality Assurance Program: New York State Experience Mara San Antonio-Gaddy, RN, MSN NYS DOH AIDS Institute Division of HIV Prevention 2010 HIV Diagnostics Conference March 24,

More information

CHILDHOOD LEAD POISONING IN NEW JERSEY

CHILDHOOD LEAD POISONING IN NEW JERSEY CHILDHOOD LEAD POISONING IN NEW JERSEY ANNUAL REPORT FISCAL YEAR 2003 (July 1, 2002 June 30, 2003) New Jersey Department of Health and Senior Services Division of Family Health Services Maternal, Child,

More information

How are testing technologies used to diagnose HIV infection?

How are testing technologies used to diagnose HIV infection? HIV testing technologies are used to determine if a person has HIV. Several types of HIV testing technologies are used in Canada. These tests differ in several ways, including where the test is conducted,

More information

Using all the data: Immunoassay signal-to-cutoff values provide useful information that should be considered in HIV diagnostic

Using all the data: Immunoassay signal-to-cutoff values provide useful information that should be considered in HIV diagnostic Using all the data: Immunoassay signal-to-cutoff values provide useful information that should be considered in HIV diagnostic algorithms KP Delaney, M Pentella, B Bennett, and K Landgraf for the CDC/APHL

More information

HIV Serology Quality Assessment Program Summary for Panel HIVSER 2017Apr19

HIV Serology Quality Assessment Program Summary for Panel HIVSER 2017Apr19 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory Public Health Agency of Canada HIV Serology Quality Assessment Program Summary

More information

CHILDHOOD LEAD POISONING IN NEW JERSEY

CHILDHOOD LEAD POISONING IN NEW JERSEY CHILDHOOD LEAD POISONING IN NEW JERSEY ANNUAL REPORT FISCAL YEAR 2002 (July 1, 2001 June 30, 2002) New Jersey Department of Health and Senior Services Division of Family Health Services Maternal, Child,

More information

Division of Mental Health and Addiction Services

Division of Mental Health and Addiction Services Division of Mental Health and Addiction Services A DAM BUCON, LSW DMHAS Mission DMHAS, in partnership with consumers, family members, providers and other stakeholders, promotes wellness and recovery for

More information

Integrating HIV Screening Into

Integrating HIV Screening Into MaxiMizing Third ParTy reimbursement for hiv TesTing Integrating HIV Screening Into Title X Services IntroductIon HIV screening services are a core family planning service, and all individuals aged 13-64

More information

Asthma in New Jersey

Asthma in New Jersey Asthma in New Jersey County Asthma Profiles Overview The New Jersey Department of Health has designed profiles of each New Jersey County presenting asthma prevalence and asthma-related emergency department

More information

Introduction. All of the County Health Rankings are based upon this model of population health improvement:

Introduction. All of the County Health Rankings are based upon this model of population health improvement: 2011 New Jersey Introduction Where we live matters to our health. The health of a community depends on many different factors, including quality of health care, individual behavior, education and jobs,

More information

Unigold Recombigen HIV 1/2 Training for HIV Testing Sites. Updated: February 2018 Cicely Richard Office of HIV/AIDS

Unigold Recombigen HIV 1/2 Training for HIV Testing Sites. Updated: February 2018 Cicely Richard Office of HIV/AIDS Unigold Recombigen HIV 1/2 Training for HIV Testing Sites Updated: February 2018 Cicely Richard Office of HIV/AIDS Updated: February 2018 Cicely Richard Office of HIV/AIDS UNIGOLD RECOMBIGEN HIV 1/2 TRAINING

More information

High Sensitivity HIV Testing and Translational Science around PrEP

High Sensitivity HIV Testing and Translational Science around PrEP High Sensitivity HIV Testing and Translational Science around PrEP Joanne Stekler, MD MPH Associate Professor, Department of Medicine University of Washington Inter-Center for AIDS Research Antiretrovirals

More information

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Hudson County

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Hudson County New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Hudson County Department of Human Services Division of Mental Health and Addiction Services Office of Planning, Research, Evaluation

More information

HIV-1 AccuVert TM Seroconversion Panel

HIV-1 AccuVert TM Seroconversion Panel PACKAGE INSERT PRB954 (0600-0238) INTENDED USE The is intended for use by diagnostic manufacturers, researchers, and clinical laboratories to develop, evaluate, or troubleshoot test methods. Characterized

More information

New Jersey HIV/AIDS Epidemiologic Overview, 2017 (Data based upon the HIV/AIDS Reporting System ehars, unless otherwise noted.)

New Jersey HIV/AIDS Epidemiologic Overview, 2017 (Data based upon the HIV/AIDS Reporting System ehars, unless otherwise noted.) New Jersey HIV/AIDS Epidemiologic Overview, 2017 (Data based upon the HIV/AIDS Reporting System ehars, unless otherwise noted.) New Jersey Department of Health Division of HIV, STD, TB Services INTRODUCTION

More information

List the steps in the fourth generation HIV screening algorithm Describe the relationship between rapid HIV antibody tests and the fourth generation

List the steps in the fourth generation HIV screening algorithm Describe the relationship between rapid HIV antibody tests and the fourth generation Alere (honoraria) List the steps in the fourth generation HIV screening algorithm Describe the relationship between rapid HIV antibody tests and the fourth generation testing algorithm Interpret challenging

More information

AccuSet HIV-1/2 Performance Panel

AccuSet HIV-1/2 Performance Panel OVERVIEW AccuSet HIV-1/2 (0800-0380) is a 13-member validation panel of undiluted, naturally occurring plasma samples (1 vial per member, 1.0 ml per vial). Panel members represent bleeds from multiple

More information

AccuVert HBV Seroconversion Panel PHM941(M) ( )

AccuVert HBV Seroconversion Panel PHM941(M) ( ) PACKAGE INSERT PHM941(M) (0605-0061) INTENDED USE PHM941(M) (0605-0061) is a group of serial bleeds from an individual plasma donor during HBV seroconversion. This panel is intended for use by diagnostics

More information

AdvaMedDx Value Assessment Framework in Practice

AdvaMedDx Value Assessment Framework in Practice AdvaMedDx Value Assessment Framework in Practice Application of the Comprehensive Assessment of the Value of Diagnostic Technologies Framework to Abbott s 4th Generation ARCHITECT HIV Antigen/Antibody

More information

HIV Serology Quality Assessment Program Summary for Panel HIVSER 2018Apr19

HIV Serology Quality Assessment Program Summary for Panel HIVSER 2018Apr19 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory Public Health Agency of Canada HIV Serology Quality Assessment Program Summary

More information

HIV-1 AccuVert Seroconversion Panel (PRB966) / Batch #

HIV-1 AccuVert Seroconversion Panel (PRB966) / Batch # s/co c/ml DATA SHEET OVERVIEW 0600-0248 (PRB966) is a 10-member panel of undiluted, naturally occurring plasma samples. Panel members represent serial bleeds collected from a single patient over the course

More information

Diagnostic Tests for HIV

Diagnostic Tests for HIV Mountain West AIDS Education and Training Center Diagnostic Tests for HIV David Spach, MD Principal Investigator, Mountain West AETC Professor of Medicine, University of Washington Last Updated: June 22,

More information

HIV Serology Quality Assessment Program Revised Summary for Panel HIVSER 2017Oct27

HIV Serology Quality Assessment Program Revised Summary for Panel HIVSER 2017Oct27 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory Public Health Agency of Canada HIV Serology Quality Assessment Program Revised

More information

Outline. Successful Integration of Hepatitis Vaccination Services into Programs for High-Risk Adults An Update of State-Based Programs

Outline. Successful Integration of Hepatitis Vaccination Services into Programs for High-Risk Adults An Update of State-Based Programs Successful Integration of Hepatitis Vaccination Services into Programs for High-Risk Adults An Update of State-Based Programs Joanna Buffington, MD, MPH Division of Viral Hepatitis National Immunization

More information

Potential Effect of Alternative HIV Testing Algorithms on HIV Case Surveillance

Potential Effect of Alternative HIV Testing Algorithms on HIV Case Surveillance Potential Effect of Alternative HIV Testing Algorithms on HIV Case Surveillance Kristen Mahle, MPH HIV Incidence & Case Surveillance Branch DHAP, NCHHSTP, CDC 2010 Diagnostics Conference March 24, 2010

More information

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Essex County

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Essex County New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Essex County Department of Human Services Division of Mental Health and Addiction Services Office of Planning, Research, Evaluation

More information

AccuSet Anti-HIV-1 Mixed Titer Performance Panel

AccuSet Anti-HIV-1 Mixed Titer Performance Panel signal to cut-off (s/co) DATA SHEET OVERVIEW PRB205(M3) is a modified 16-member panel originating from Anti- HIV-1 Mixed Titer PRB205(M2). Panel members 3, 5, 6, 17, 21, 22, 23, 24, and 25 from the original

More information

SP.718 Special Topics at Edgerton Center: D-Lab Health: Medical Technologies for the Developing World

SP.718 Special Topics at Edgerton Center: D-Lab Health: Medical Technologies for the Developing World MIT OpenCourseWare http://ocw.mit.edu SP.718 Special Topics at Edgerton Center: D-Lab Health: Medical Technologies for the Developing World Spring 2009 For information about citing these materials or our

More information

New Jersey HIV Planning Group Main Meeting September 15, 2016

New Jersey HIV Planning Group Main Meeting September 15, 2016 New Jersey HIV Planning Group Main Meeting September 15, 2016 Commissioner Division of HIV, STD and TB Services RYAN WHITE MOVING FORWARD Shared Mission RFA Funding Decisions Based on meeting the goals

More information

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2017 Morris County

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2017 Morris County New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2017 Morris County Department of Health Division of Mental Health and Addiction Services Office of Planning, Research, Evaluation and

More information

Hepatitis C January 26, 2018

Hepatitis C January 26, 2018 Hepatitis C January 26, 2018 Case Investigation Guidelines Contents A. Purpose...2 B. Case Definitions...2 a. Acute Hepatitis C (2016...2 b. Chronic Hepatitis C (2016)...3 c. Perinatal Hepatitis C (2017

More information

Improving Patient Engagement in HIV Care: Health Department Strategies

Improving Patient Engagement in HIV Care: Health Department Strategies University of Washington Public Health Capacity Building Center Improving Patient Engagement in HIV Care: Health Department Strategies Julie Dombrowski, MD, MPH Deputy Director, PHSKC HIV/STD Program Assistant

More information

Resources Categorized by Issue

Resources Categorized by Issue Resources Categorized by Issue Alzheimer s Disease, Dementia, and Related Disorders Rutgers UBHC Comprehensive Services on Aging (COPSA) Community Outreach Program... 52 Anger Management Catholic Charities

More information

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Passaic County

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Passaic County New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Passaic County Department of Human Services Division of Mental Health and Addiction Services Office of Planning, Research, Evaluation

More information

OR: Steps you can take in the clinic to prevent HIV infections

OR: Steps you can take in the clinic to prevent HIV infections Implementing Changes to Reduce HIV Incidence: Synergies between Public Health and Primary Care Kevin Ard, MD, MPH Brigham and Women s Hospital, Massachusetts General Hospital, and the Fenway Institute

More information

FY 17 EIIHA PLAN Early Identification of Individuals with HIV/AIDS

FY 17 EIIHA PLAN Early Identification of Individuals with HIV/AIDS 1) EIIHA a) Plan for linking people to prevention and care services. Include community partners and other resources utilized and major collaborations. The EMA s EIIHA strategy focuses on five areas for

More information

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Hunterdon County

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Hunterdon County New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Hunterdon County Department of Human Services Division of Mental Health and Addiction Services Office of Planning, Research, Evaluation

More information

Women s Health at Risk. A report on the status of women s health in New Jersey

Women s Health at Risk. A report on the status of women s health in New Jersey Women s Health at Risk A report on the status of women s health in New Jersey May 2015 New Jersey Women s Reproductive Health Overview As more New Jersey residents gained access to insurance through the

More information

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Middlesex County

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Middlesex County New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Middlesex County Department of Human Services Division of Mental Health and Addiction Services Office of Planning, Research, Evaluation

More information

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Statewide

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Statewide New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Statewide Department of Human Services Division of Mental Health and Addiction Services Office of Planning, Research, Evaluation

More information

New Jersey Alliance of Family Support Organizations Annual Membership Report

New Jersey Alliance of Family Support Organizations Annual Membership Report New Jersey Alliance of Family Support Organizations Annual Membership Report 2011-2012 Helping youth with emotional, behavioral, and mental health needs and their families 1 Why the New Jersey Alliance

More information

ROUTINE HIV SCREENING

ROUTINE HIV SCREENING RT_Handbook_update 5/14/12 12:07 PM Page a How-to Guide for DC Medical Providers ROUTINE HIV SCREENING IMPLEMENTATION HANDBOOK RT_Handbook_update 5/14/12 12:07 PM Page b RT_Handbook_update 5/14/12 12:07

More information

State of California Health and Human Services Agency Department of Health Services

State of California Health and Human Services Agency Department of Health Services State of California Health and Human Services Agency Department of Health Services SANDRA SHEWRY Director ARNOLD SCHWARZENEGGER Governor TO: INTERESTED PARTIES SUBJECT: CALIFORNIA HIV SEROPREVALENCE ANNUAL

More information

Failure of the Alere Determine 4th Generation HIV POC test to Detect an Acute Case of HIV-1 Infection

Failure of the Alere Determine 4th Generation HIV POC test to Detect an Acute Case of HIV-1 Infection Failure of the Alere Determine 4th Generation HIV POC test to Detect an Acute Case of HIV-1 Infection Carol Loring, MS Rachel Gridley Fengxiang Gao, MD, MPH NH Public Health Laboratories Concord, NH Conflicts

More information